Unknown

Dataset Information

0

Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer.


ABSTRACT: The application of new technologies for gene editing in horses may allow the generation of improved sportive individuals. Here, we aimed to knock out the myostatin gene (MSTN), a negative regulator of muscle mass development, using CRISPR/Cas9 and to generate edited embryos for the first time in horses. We nucleofected horse fetal fibroblasts with 1, 2 or 5 µg of 2 different gRNA/Cas9 plasmids targeting the first exon of MSTN. We observed that increasing plasmid concentrations improved mutation efficiency. The average efficiency was 63.6% for gRNA1 (14/22 edited clonal cell lines) and 96.2% for gRNA2 (25/26 edited clonal cell lines). Three clonal cell lines were chosen for embryo generation by somatic cell nuclear transfer: one with a monoallelic edition, one with biallelic heterozygous editions and one with a biallelic homozygous edition, which rendered edited blastocysts in each case. Both MSTN editions and off-targets were analyzed in the embryos. In conclusion, CRISPR/Cas9 proved an efficient method to edit the horse genome in a dose dependent manner with high specificity. Adapting this technology sport advantageous alleles could be generated, and a precision breeding program could be developed.

SUBMITTER: Moro LN 

PROVIDER: S-EPMC7518276 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer.

Moro Lucia Natalia LN   Viale Diego Luis DL   Bastón Juan Ignacio JI   Arnold Victoria V   Suvá Mariana M   Wiedenmann Elisabet E   Olguín Martín M   Miriuka Santiago S   Vichera Gabriel G  

Scientific reports 20200924 1


The application of new technologies for gene editing in horses may allow the generation of improved sportive individuals. Here, we aimed to knock out the myostatin gene (MSTN), a negative regulator of muscle mass development, using CRISPR/Cas9 and to generate edited embryos for the first time in horses. We nucleofected horse fetal fibroblasts with 1, 2 or 5 µg of 2 different gRNA/Cas9 plasmids targeting the first exon of MSTN. We observed that increasing plasmid concentrations improved mutation  ...[more]

Similar Datasets

| S-EPMC8179174 | biostudies-literature
| S-EPMC10594749 | biostudies-literature
| S-EPMC9281017 | biostudies-literature
| S-EPMC5544710 | biostudies-literature
| S-EPMC5630377 | biostudies-literature
| S-EPMC7156422 | biostudies-literature
| S-EPMC6540458 | biostudies-literature
| S-EPMC4549068 | biostudies-literature
| S-EPMC3143123 | biostudies-literature
| S-EPMC8911381 | biostudies-literature